A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide

The antibiotic pyrazinamide is central to tuberculosis treatment regimens, globally. Despite its efficacy, resistance to the drug is increasing. Here, Eric Rubin and colleagues characterise the genetic basis of pyrazinamide resistance.

Saved in:
Bibliographic Details
Main Authors: Adam N. Yadon, Kashmeel Maharaj, John H. Adamson, Yi-Pin Lai, James C. Sacchettini, Thomas R. Ioerger, Eric J. Rubin, Alexander S. Pym
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Q
Online Access:https://doaj.org/article/64b393ee6e854aef8a3dc9823de250ff
Tags: Add Tag
No Tags, Be the first to tag this record!